Angiomyolipoma differential diagnosis: Difference between revisions
Jump to navigation
Jump to search
Line 39: | Line 39: | ||
| doi = 10.1097/PAP.0000000000000101 | | doi = 10.1097/PAP.0000000000000101 | ||
| pmid = 26645460 | | pmid = 26645460 | ||
}}</ref> | }}</ref><ref name="pmid470981">{{cite journal| author=Cohen AJ, Li FP, Berg S, Marchetto DJ, Tsai S, Jacobs SC et al.| title=Hereditary renal-cell carcinoma associated with a chromosomal translocation. | journal=N Engl J Med | year= 1979 | volume= 301 | issue= 11 | pages= 592-5 | pmid=470981 | doi=10.1056/NEJM197909133011107 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=470981 }}</ref> | ||
{| style="border: 0px; font-size: 90%; margin: 3px; width: 800px" align=center | {| style="border: 0px; font-size: 90%; margin: 3px; width: 800px" align=center | ||
|valign=top| | |valign=top| |
Latest revision as of 13:17, 6 November 2019
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Faizan Sheraz, M.D. [2],Rekha, M.D.
Overview
Angiomyolipoma must be differentiated from retroperitoneal liposarcoma, adrenal myelolipoma, and renal cell carcinoma.[1][2]
Differentiating Angiomyolipoma from other Diseases
Angiomyolipoma must be differentiated from the following:[1][3][4][5][6]
Differential diagnosis | Characteristic features of the differential diagnosis |
---|---|
| |
| |
| |
| |
|
|
| |
|
|
|
|
|
|
References
- ↑ 1.0 1.1 Patil, PA.; McKenney, JK.; Trpkov, K.; Hes, O.; Montironi, R.; Scarpelli, M.; Nesi, G.; Aron, M.; Sangoi, AR. (2014). "Renal Leiomyoma: A Contemporary Multi-institution Study of an Infrequent and Frequently Misclassified Neoplasm". Am J Surg Pathol. doi:10.1097/PAS.0000000000000354. PMID 25517956. Unknown parameter
|month=
ignored (help) - ↑ Renal angiomyolipoma differential diagnosis. Dr Matt A. Morgan and Dr Behrang Amini et al. Radiopaedia 2015. http://radiopaedia.org/articles/renal-angiomyolipoma
- ↑ N. Azumi, J. Curtis, R. L. Kempson & M. R. Hendrickson (1987). "Atypical and malignant neoplasms showing lipomatous differentiation. A study of 111 cases". The American journal of surgical pathology. 11 (3): 161–183. PMID 3826477. Unknown parameter
|month=
ignored (help) - ↑ Emily Z. Keung, Jason L. Hornick, Monica M. Bertagnolli, Elizabeth H. Baldini & Chandrajit P. Raut (2014). "Predictors of outcomes in patients with primary retroperitoneal dedifferentiated liposarcoma undergoing surgery". Journal of the American College of Surgeons. 218 (2): 206–217. doi:10.1016/j.jamcollsurg.2013.10.009. PMID 24315890. Unknown parameter
|month=
ignored (help) - ↑ Khin Thway, Robin L. Jones, Jonathan Noujaim, Shane Zaidi, Aisha B. Miah & Cyril Fisher (2016). "Dedifferentiated Liposarcoma: Updates on Morphology, Genetics, and Therapeutic Strategies". Advances in anatomic pathology. 23 (1): 30–40. doi:10.1097/PAP.0000000000000101. PMID 26645460. Unknown parameter
|month=
ignored (help) - ↑ Cohen AJ, Li FP, Berg S, Marchetto DJ, Tsai S, Jacobs SC; et al. (1979). "Hereditary renal-cell carcinoma associated with a chromosomal translocation". N Engl J Med. 301 (11): 592–5. doi:10.1056/NEJM197909133011107. PMID 470981.
- ↑ Kate Lynn J. Bill, Lucia Casadei, Bethany C. Prudner, Hans Iwenofu, Anne M. Strohecker & Raphael E. Pollock (2016). "Liposarcoma: molecular targets and therapeutic implications". Cellular and molecular life sciences : CMLS. 73 (19): 3711–3718. doi:10.1007/s00018-016-2266-2. PMID 27173057. Unknown parameter
|month=
ignored (help) - ↑ Cohen HT, McGovern FJ (2005). "Renal-cell carcinoma". N Engl J Med. 353 (23): 2477–90. doi:10.1056/NEJMra043172. PMID 16339096.